ProtaGene at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
ProtaGene brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on measuring what a vector or an edit actually did. Topics include high-sensitivity sequencing that reads gene editing outcomes from preclinical work through patient monitoring and a comparison of three methods for assessing integration sites.
| Organization | ESGCT 2026 Attendance |
|---|---|
ProtaGene Heilbronn, Germany | |
Analytical services provider whose cell and gene unit tests vectors, integration sites and gene editing outcomes. | Poster Wed Oct 28 1:30pm–3:30pm A high-sensitivity Target Enrichment Sequencing approach for detection and characterization of gene editing outcomes for all stages from preclinical development to patient treatment and monitoring Poster Thu Oct 29 2:00pm–4:00pm Comprehensive Safety Assessment of Vector Integration Sites via S‑EPTS/LM‑PCR, TES, and WGS. |
Instantly find 20 buyers from ProtaGene
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction